EMA Authorised: Stribild (elvitegravir;cobicistat;emtricitabine;tenofovir disoproxil fumarate) — Gilead Sciences Ireland UC

View source ↗

Summary

The EMA authorised Stribild, a fixed-dose combination of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, for HIV infections, with Gil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Gilead Sciences Ireland UC. Decision date: 27/06/2024